checkAd
    Startseite > Aktien > Abionyx Pharma Share > Nachrichten
    Abionyx Pharma Share Aktie
    1,0440
     
    EUR
    -0,48 %
    -0,0050 EUR
    Letzter Kurs 08.05.24 Lang & Schwarz
    0,9800
     
    EUR
    911 STK
    Geldkurs 08.05.24
    1,1080
     
    EUR
    911 STK
    Briefkurs 08.05.24
    ISIN: FR0012616852 · WKN: A14QR9 · Frankreich

    Neueste Nachrichten

    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    07.05.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Availability of the Universal Registration Document for the Year 2023
    02.05.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    10.04.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma - Bpifrance Supports the Development of CER-001 in Ophthalmology With a Nearly €1 Million Non-dilutive Innovation Grant
    14.03.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    11.03.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma Announces Its 2023 Full-Year Financial Results
    11.03.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma announces its financial calendar for the year 2024
    07.03.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 4th Quarter 2023
    29.02.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Clarification About Clinical Results From the Phase 3 of apoA-I study, CSL112
    16.02.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring’s Human-plasma-derived apoA-I, CSL112
    15.02.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    06.02.24 · Business Wire (engl.) · Abionyx Pharma Share
    ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
    04.01.24 · Business Wire (engl.) · Abionyx Pharma Share